A Phase IV, single dose, open labelled, comparative, randomized controlled study to evaluate the immunogenicity and safety of BBIL's JENVAC (Inactivated JE Vaccine) vs. Chinese SA-14-14-2 (Live JE Vaccine) vaccine in healthy volunteers.

Trial Profile

A Phase IV, single dose, open labelled, comparative, randomized controlled study to evaluate the immunogenicity and safety of BBIL's JENVAC (Inactivated JE Vaccine) vs. Chinese SA-14-14-2 (Live JE Vaccine) vaccine in healthy volunteers.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Japanese encephalitis vaccine (Primary) ; Japanese encephalitis vaccine (Primary)
  • Indications Japanese encephalitis
  • Focus Pharmacodynamics
  • Sponsors Bharat Biotech
  • Most Recent Events

    • 19 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top